Á¦8ȸ ´ë»ç¼º°ñÁúȯ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-08±³À°ÀÏÀÚ : 2018-09-08
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ¾çÀ±¼±È¦
±³À°ÁÖÁ¦ :
Á¦8ȸ ´ë»ç¼º°ñÁúȯ¿¬±¸È¸ ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ë»ç¼º°ñÁúȯ¿¬±¸È¸
´ã´çÀÚ : À̽ÃÈÆ
¿¬¶ôó : 032-458-2662
À̸ÞÀÏ :
shleemd@gachon.ac.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 09:00~09:25 Hypophosphatemia: from pathophysioloy to treatment Á¤ÇØÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 09:25~09:50 Hereditary hypophosphatemia ÀÌÀ¯¹Ì(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 09:50~10:15 New drug for FGF23-related hypophosphatemic diseases ³²¹Ù(¿À»çÄ«ÀÇ´ë)
Åä·Ð 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 10:15~10:30 Åä·Ð ()
ÈÞ½Ä 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 10:30~10:50 ÈÞ½Ä ()
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 10:50~11:15 Bone and diabetes ÃÖ¿ëÁØ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 11:15~11:40 Bone and parathyroid diseases È«¾Æ¶÷(Àü³²ÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 11:40~12:05 Bone and thyroid diseases Á¶¼±¿í(¼¿ïÀÇ´ë)
Åä·Ð 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 12:05~12:20 Åä·Ð ()
½Ä»ç 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 12:20~13:20 ½Ä»ç ()
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 13:20~13:45 PTH assay: where we stand À̽ÃÈÆ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 13:45~14:10 Ultimatum diagnosis on unlocalized primary hyperparathyroidism È«³²±â(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 14:10~14:35 Pathology of parathyroid diseases ±èÈñ¼º(Áß¾ÓÀÇ´ë)
Åä·Ð 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 14:35~14:50 Åä·Ð ()
ÈÞ½Ä 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 14:50~15:10 ÈÞ½Ä ()
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 15:10~15:35 Assessment of bone health in CKD patients ¾È¼ºÈñ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 15:35~15:50 Treatment of osteoporosis in CKD patients ±èºÎ°æ(°í½ÅÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 15:50~16:15 Parathyroid surgery in the management of hyperparathyroidism 俵ÁØ(¼¿ïÀÇ´ë)
Åä·Ð 09¿ù 08ÀÏ ¾çÀ±¼±È¦ 16:15~16:30 Åä·Ð ()